BACKGROUND: Electroporation uses an electric field to induce pores in the cell membrane that can transfer macromolecules into target cells. Modulation of electrical parameters leads to irreversible electroporation (IRE), which is being developed for tissue ablation. We sought to evaluate whether the application of IRE may induce a lesser electric field in the periphery where reversible electroporation may occur, facilitating gene transfer of a granulocyte macrophage colony-stimulating factor (GM-CSF) plasmid to produce its biologic response. METHODS: Yorkshire pigs underwent laparotomy, and IRE of the liver was performed during hepatic arterial infusion of 1 or 7 mg of a naked human GM-CSF plasmid. The serum, liver, lymph nodes, and bone marrow were harvested for analysis. RESULTS: Human GM-CSF level rose from undetectable to 131 pg/mL in the serum at 24 hours after IRE and plasmid infusion. The liver demonstrated an ablation zone surrounded by an immune infiltrate that had greater macrophage intensity than when treated with IRE or plasmid infusion alone. This dominance of macrophages was dose dependent. Distant effects of GM-CSF were found in the bone marrow, where proliferating myeloid cells increased from 14% to 25%. CONCLUSION: IRE facilitated gene transfer of the GM-CSF plasmid and brought about a local and systemic biologic response. This technique holds potential for tumor eradication and immunotherapy of residual cancer.
BACKGROUND: Electroporation uses an electric field to induce pores in the cell membrane that can transfer macromolecules into target cells. Modulation of electrical parameters leads to irreversible electroporation (IRE), which is being developed for tissue ablation. We sought to evaluate whether the application of IRE may induce a lesser electric field in the periphery where reversible electroporation may occur, facilitating gene transfer of a granulocyte macrophage colony-stimulating factor (GM-CSF) plasmid to produce its biologic response. METHODS: Yorkshire pigs underwent laparotomy, and IRE of the liver was performed during hepatic arterial infusion of 1 or 7 mg of a naked humanGM-CSF plasmid. The serum, liver, lymph nodes, and bone marrow were harvested for analysis. RESULTS:HumanGM-CSF level rose from undetectable to 131 pg/mL in the serum at 24 hours after IRE and plasmid infusion. The liver demonstrated an ablation zone surrounded by an immune infiltrate that had greater macrophage intensity than when treated with IRE or plasmid infusion alone. This dominance of macrophages was dose dependent. Distant effects of GM-CSF were found in the bone marrow, where proliferating myeloid cells increased from 14% to 25%. CONCLUSION: IRE facilitated gene transfer of the GM-CSF plasmid and brought about a local and systemic biologic response. This technique holds potential for tumor eradication and immunotherapy of residual cancer.
Authors: Y I Yamashita; M Shimada; H Hasegawa; R Minagawa; T Rikimaru; T Hamatsu; S Tanaka; K Shirabe; J I Miyazaki; K Sugimachi Journal: Cancer Res Date: 2001-02-01 Impact factor: 12.701
Authors: Robert E Neal; Ravi Singh; Heather C Hatcher; Nancy D Kock; Suzy V Torti; Rafael V Davalos Journal: Breast Cancer Res Treat Date: 2010-02-27 Impact factor: 4.872
Authors: Edward W Lee; Christine Chen; Veronica E Prieto; Sarah M Dry; Christopher T Loh; Stephen T Kee Journal: Radiology Date: 2010-05 Impact factor: 11.105
Authors: Yang Guo; Yue Zhang; Rachel Klein; Grace M Nijm; Alan V Sahakian; Reed A Omary; Guang-Yu Yang; Andrew C Larson Journal: Cancer Res Date: 2010-02-02 Impact factor: 12.701
Authors: J W Fabre; A Grehan; M Whitehorne; G J Sawyer; X Dong; S Salehi; L Eckley; X Zhang; M Seddon; A M Shah; M Davenport; M Rela Journal: Gene Ther Date: 2007-11-15 Impact factor: 5.250
Authors: Adil I Daud; Ronald C DeConti; Stephanie Andrews; Patricia Urbas; Adam I Riker; Vernon K Sondak; Pamela N Munster; Daniel M Sullivan; Kenneth E Ugen; Jane L Messina; Richard Heller Journal: J Clin Oncol Date: 2008-11-24 Impact factor: 44.544
Authors: Miguel-Angel Perales; Jianda Yuan; Sarah Powel; Humilidad F Gallardo; Teresa S Rasalan; Christina Gonzalez; Gregor Manukian; Jian Wang; Yan Zhang; Paul B Chapman; Susan E Krown; Philip O Livingston; Samuel Ejadi; Katherine S Panageas; Manuel E Engelhorn; Stephanie L Terzulli; Alan N Houghton; Jedd D Wolchok Journal: Mol Ther Date: 2008-09-16 Impact factor: 11.454
Authors: J A Vogel; E van Veldhuisen; P Agnass; J Crezee; F Dijk; J Verheij; T M van Gulik; M R Meijerink; L G Vroomen; K P van Lienden; M G Besselink Journal: PLoS One Date: 2016-11-21 Impact factor: 3.240
Authors: Jantien A Vogel; Eran van Veldhuisen; Lindy K Alles; Olivier R Busch; Frederike Dijk; Thomas M van Gulik; Goos M Huijzer; Marc G Besselink; Krijn P van Lienden; Joanne Verheij Journal: Technol Cancer Res Treat Date: 2019-01-01
Authors: Brandon J Burbach; Stephen D O'Flanagan; Qi Shao; Katharine M Young; Joseph R Slaughter; Meagan R Rollins; Tami Jo L Street; Victoria E Granger; Lalit K Beura; Samira M Azarin; Satish Ramadhyani; Bruce R Forsyth; John C Bischof; Yoji Shimizu Journal: Nat Commun Date: 2021-06-23 Impact factor: 17.694